Sam Chun Dang Pharm. Co., Ltd (000250.KQ)
KRW 141800.0
(1.29%)
KRW 141800.0
(1.29%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 35.26 Billion KRW | 10.5% |
| 2022 | 31.91 Billion KRW | 14.35% |
| 2021 | 27.9 Billion KRW | 10.15% |
| 2020 | 25.33 Billion KRW | 9.99% |
| 2019 | 23.03 Billion KRW | 2.7% |
| 2018 | 22.42 Billion KRW | 2.66% |
| 2017 | 21.84 Billion KRW | 13.97% |
| 2016 | 19.17 Billion KRW | 8.08% |
| 2015 | 17.73 Billion KRW | 4.5% |
| 2014 | 16.97 Billion KRW | 6.55% |
| 2013 | 15.93 Billion KRW | 2.31% |
| 2012 | 15.57 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 39.86 Billion KRW | 2.81% |
| 2024 Q1 | 38.77 Billion KRW | 9.95% |
| 2023 Q2 | 35.55 Billion KRW | 7.38% |
| 2023 Q1 | 33.11 Billion KRW | 3.75% |
| 2023 FY | 35.26 Billion KRW | 10.5% |
| 2023 Q4 | 35.26 Billion KRW | -7.98% |
| 2023 Q3 | 38.31 Billion KRW | 7.77% |
| 2022 Q4 | 31.91 Billion KRW | 1.69% |
| 2022 FY | 31.91 Billion KRW | 14.35% |
| 2022 Q3 | 31.38 Billion KRW | 3.75% |
| 2022 Q2 | 30.24 Billion KRW | 2.6% |
| 2022 Q1 | 29.48 Billion KRW | 5.64% |
| 2021 Q3 | 26.16 Billion KRW | 10.12% |
| 2021 Q4 | 27.9 Billion KRW | 6.66% |
| 2021 FY | 27.9 Billion KRW | 10.15% |
| 2021 Q2 | 23.76 Billion KRW | -0.5% |
| 2021 Q1 | 23.88 Billion KRW | -5.75% |
| 2020 Q1 | 24.74 Billion KRW | 7.42% |
| 2020 Q3 | 24.9 Billion KRW | 4.65% |
| 2020 Q4 | 25.33 Billion KRW | 1.72% |
| 2020 Q2 | 23.79 Billion KRW | -3.81% |
| 2020 FY | 25.33 Billion KRW | 9.99% |
| 2019 Q3 | 22.42 Billion KRW | -2.49% |
| 2019 Q2 | 22.99 Billion KRW | 3.59% |
| 2019 Q1 | 22.19 Billion KRW | -1.03% |
| 2019 FY | 23.03 Billion KRW | 2.7% |
| 2019 Q4 | 23.03 Billion KRW | 2.72% |
| 2018 Q2 | 22.96 Billion KRW | 3.84% |
| 2018 Q1 | 22.11 Billion KRW | 1.2% |
| 2018 Q4 | 22.42 Billion KRW | 0.03% |
| 2018 FY | 22.42 Billion KRW | 2.66% |
| 2018 Q3 | 22.42 Billion KRW | -2.34% |
| 2017 FY | 21.84 Billion KRW | 13.97% |
| 2017 Q2 | 21.59 Billion KRW | 8.6% |
| 2017 Q3 | 21.52 Billion KRW | -0.33% |
| 2017 Q4 | 21.84 Billion KRW | 1.49% |
| 2017 Q1 | 19.88 Billion KRW | 3.75% |
| 2016 Q3 | 18.78 Billion KRW | 4.21% |
| 2016 FY | 19.17 Billion KRW | 8.08% |
| 2016 Q1 | 17.37 Billion KRW | -2.02% |
| 2016 Q4 | 19.17 Billion KRW | 2.05% |
| 2016 Q2 | 18.02 Billion KRW | 3.72% |
| 2015 Q1 | 16.41 Billion KRW | -3.3% |
| 2015 Q4 | 17.73 Billion KRW | -4.59% |
| 2015 Q3 | 18.59 Billion KRW | 7.54% |
| 2015 Q2 | 17.28 Billion KRW | 5.32% |
| 2015 FY | 17.73 Billion KRW | 4.5% |
| 2014 Q1 | 17.13 Billion KRW | 7.56% |
| 2014 FY | 16.97 Billion KRW | 6.55% |
| 2014 Q3 | 16.94 Billion KRW | 0.9% |
| 2014 Q2 | 16.79 Billion KRW | -2.0% |
| 2014 Q4 | 16.97 Billion KRW | 0.18% |
| 2013 Q1 | 16.82 Billion KRW | 8.06% |
| 2013 Q2 | 16.44 Billion KRW | -2.26% |
| 2013 FY | 15.93 Billion KRW | 2.31% |
| 2013 Q3 | 15.81 Billion KRW | -3.84% |
| 2013 Q4 | 15.93 Billion KRW | 0.73% |
| 2012 FY | 15.57 Billion KRW | 0.0% |
| 2012 Q4 | 15.57 Billion KRW | 26.12% |
| 2012 Q3 | 12.34 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Hyundai Bioscience Co., Ltd. | 2.58 Billion KRW | -1262.465% |
| ST Pharm Co.,Ltd. | 120.73 Billion KRW | 70.794% |
| ABL Bio Inc. | - KRW | -Infinity% |
| Cellid, Co., Ltd. | - KRW | -Infinity% |